openPR Logo
Press release

Major Boost to the Global Esomeprazole Magnesium Market Analysis Forecast 2020-2025 | AstraZeneca, Radiant Pharmacuticals, Teva Pharmaceuticals, Mylan, Torrent Pharmaceutical, Camber

10-20-2020 07:04 PM CET | Health & Medicine

Press release from: Business Industry Reports

Esomeprazole Magnesium

Esomeprazole Magnesium

The growing demand for Esomeprazole Magnesium has provided a major boost to the Global Esomeprazole Magnesium Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2025.

Global Esomeprazole Magnesium Market overview:

Prescription esomeprazole is used to treat the symptoms of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 1 year of age and older. The Global Esomeprazole Magnesium Market is segmented on the basis of Product Type, Application, End Use Industry and Region. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/252926 .

On the Basis of Product Type segment, the Esomeprazole Magnesium Market is sub segmented into Capsules and Tablet. Based on End Use Industry segment, the Esomeprazole Magnesium Market is segmented as Antiulcer Agents and Acid Suppressants.

There are several manufacturers of Esomeprazole Magnesium in Europe and North America. In North America, the demand for Esomeprazole Magnesium is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Esomeprazole Magnesium Market Report 2020” @ https://www.businessindustryreports.com/buy-now/252926/single .

Top Industry News:

Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY (fremanezumab-vfrm) Injection Published in Headache on 07 October, 2020 -- Teva Pharmaceutical Industries Ltd. today announced results from a post hoc analysis of a long-term, open-label extension study assessing migraine days at the beginning and end of quarterly and monthly dosing intervals of AJOVY (fremanezumab-vfrm) injection. The results were published in the October issue of Headache: The Journal of Head and Face Pain.

“We are proud to share this analysis and demonstrate our continued commitment to advancing the understanding of treatment options for patients living with migraine,” said Denisa Hurtukova, MD, Vice President, Head of North America Medical Affairs, Teva. “This analysis helps us better understand patients’ experience with AJOVY, as well as the impact of quarterly and monthly dosing options.”

The post hoc analysis compared migraine days in the initial and final weeks of quarterly or monthly dosing regimens of AJOVY during up to 15 months of treatment. The analysis included 1,043 patients with chronic migraine (CM) (n=611) and episodic migraine (EM) (n=432) who were initially enrolled in the pivotal placebo controlled HALO CM and EM studies and then continued in the long-term, 12-month, multicenter, randomized, parallel group Phase 3 study with double blind dosing regimens. Patients received AJOVY either quarterly or monthly.

“Utilizing patients within each dosing group as their own control, we were able to analyze whether there was variability in migraine days over the course of a dosing regimen. For all time intervals analyzed, the frequency of migraine days was the same in the beginning and end of the dosing period,” said Joshua M. Cohen, MD, MPH, FAHS, Global Medical Therapeutic Area Lead for Migraine & Headache, Teva.

“This is an important analysis for the migraine community since clinical symptoms often return or worsen before the next dose of many preventive migraine medications is due,” said Andrew Blumenfeld, MD, Headache Center of Southern California, The Neurology Center, Carlsbad, CA. “Migraine can be a debilitating disease, so evaluating migraine days throughout a dosing regimen can be significant for healthcare providers when considering treatment options. Whenever the brain is exposed to a migraine attack, there is the possibility of increased sensitization with progressive worsening of the frequency of migraine. A key clinical goal is to limit the amount of time the brain is exposed to migraine to reduce this risk and the number of migraine days impacting a patient before their next dose.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/252926 .

Major Key Players:

Some of the Esomeprazole Magnesium Market manufacturers involved in the market are AstraZeneca, Radiant Pharmacuticals, Teva Pharmaceuticals, Mylan, Torrent Pharmaceutical and Camber Pharmaceuticals in World, effective mergers are some of the strategies adopted by the Esomeprazole Magnesium Market manufacturers. New product launches and continuous technological innovations are the Esomeprazole Magnesium Market strategies adopted by the major players.

Table of Contents:

1 Esomeprazole Magnesium Product Definition
2 Global Esomeprazole Magnesium Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Esomeprazole Magnesium Shipments
2.2 Global Manufacturer Esomeprazole Magnesium Business Revenue
2.3 Global Esomeprazole Magnesium Market Overview
3 Manufacturer Esomeprazole Magnesium Business Introduction
3.1 AstraZeneca Esomeprazole Magnesium Business Introduction
3.1.1 AstraZeneca Esomeprazole Magnesium Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 AstraZeneca Esomeprazole Magnesium Business Distribution by Region
3.1.3 AstraZeneca Interview Record
3.1.4 AstraZeneca Esomeprazole Magnesium Business Profile
3.1.5 AstraZeneca Esomeprazole Magnesium Product Specification
3.2 Radiant Pharmacuticals Esomeprazole Magnesium Business Introduction
3.2.1 Radiant Pharmacuticals Esomeprazole Magnesium Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Radiant Pharmacuticals Esomeprazole Magnesium Business Distribution by Region
3.2.3 Interview Record
3.2.4 Radiant Pharmacuticals Esomeprazole Magnesium Business Overview
3.2.5 Radiant Pharmacuticals Esomeprazole Magnesium Product Specification
3.3 Teva Pharmaceuticals Esomeprazole Magnesium Business Introduction
3.3.1 Teva Pharmaceuticals Esomeprazole Magnesium Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Teva Pharmaceuticals Esomeprazole Magnesium Business Distribution by Region
3.3.3 Interview Record
3.3.4 Teva Pharmaceuticals Esomeprazole Magnesium Business Overview
3.3.5 Teva Pharmaceuticals Esomeprazole Magnesium Product Specification
3.4 Mylan Esomeprazole Magnesium Business Introduction
3.5 Torrent Pharmaceutical Esomeprazole Magnesium Business Introduction
3.6 Camber Pharmaceuticals Esomeprazole Magnesium Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Major Boost to the Global Esomeprazole Magnesium Market Analysis Forecast 2020-2025 | AstraZeneca, Radiant Pharmacuticals, Teva Pharmaceuticals, Mylan, Torrent Pharmaceutical, Camber here

News-ID: 2166052 • Views: 2184

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Esomeprazole

Esomeprazole Market 2020 Globally Size, Regional Analysis, Share, Business Growt …
Esomeprazole is a compound isomer of omeprazole that is administered in the magnesium salt form. It is sold under the name of Nexium and used for the treatment of esophagitis, gastroesophageal reflux disease, peptic ulcer, reduces stomach acid and Zollinger–Ellison syndrome. The route of administration of esomeprazole is oral or injected directly into vein. Further, it has many side effects such as headache, constipation, dry mouth, abdominal pain, and some
Esomeprazole Market Size, Share, Growth, Research and Forecast 2020-2026
The esomeprazole market is expected to witness a modest growth rate during the forecast period 2020-2026. It is a proton pump inhibitor used to treat acid-related diseases. The high incidence of gastroesophageal reflux disease (GERD) is the chief reason for the growth of the market all across the globe. Its branded version is sold as Nexium, by AstraZeneca plc. It is among the most revenue-generating drug all across the globe,
Global Esomeprazole Market 2020-2025 || Stryker Corporation, Sandoz, Saval Pharm …
Eon Market Research has provided a complete research study on Global Esomeprazole Market which portrays the current market situation along with the past, present, and futuristic aspects in the Esomeprazole market. In the beginning, the report represents elemental information about the Esomeprazole industry, which contains the basic overview Product Type ( Capsule, Tablet, Else ), By End User Application ( Children, Adult, The old ), By Sector: Opportunities and Forecast
Global Esomeprazole Sodium Market Report 2018: Top Organazations, Opportunities …
Esomeprazole Sodium is a proton pump inhibitor that lowers stomach acid. It is used to treat indigestion, peptic ulcer disease, gastroesophageal reflux disease and Zollinger-Ellison syndrome. In 2017, the global Esomeprazole Sodium market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global Esomeprazole Sodium status, future forecast, growth opportunity,
Esomeprazole Magnesium Trihytrate Market 2018 Future Status till 2023
Future Market Reports on Global Esomeprazole Magnesium Trihytrate 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Esomeprazole Magnesium Trihytrate Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Esomeprazole Magnesium Trihytrate market players and the future prospects from various angles in detail. Industry
Proton Pump Inhibitors (PPIs) Market 2017 - Pantoprazole, Omeprazole, Lansoprazo …
Worldwide Proton Pump Inhibitors (PPIs) Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Proton Pump Inhibitors (PPIs) piece of the overall industry and Growth patterns, concentrating on driving Proton Pump Inhibitors (PPIs) industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022. Get Free Sample Copy of Report Here: https://goo.gl/ydpu7k Top Manufacturers Analysis of This Report AstraZeneca, Pfizer, Janssen, Eisai, Eli Lilly, Cadila Pharmaceuticals, Santarus,